Results 1 to 10 of about 2,069,243 (304)

Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations [PDF]

open access: yesCentral European Journal of Immunology
In adult-onset asthma, two major endotypes have been proposed: T2 with eosinophilia and non-T2 characterised by neutrophils and interleukin (IL)-17. The objective of the study was to examine the endotype marker profile in patients with severe asthma who were hospitalized for exacerbations, with a focus on differentiating between viral and non-viral ...
Kosar M. Ali   +6 more
doaj   +5 more sources

Pruritus as a Distinctive Feature of Type 2 Inflammation [PDF]

open access: yesVaccines, 2021
Pruritus is a common symptom of several skin diseases, both inflammatory and neoplastic. Pruritus might have a tremendous impact on patients’ quality of life and strongly interfere with sleep, social, and work activities.
Simone Garcovich   +5 more
doaj   +5 more sources

Beyond CCR7: dendritic cell migration in type 2 inflammation [PDF]

open access: yesFrontiers in Immunology
Conventional dendritic cells (cDCs) are crucial antigen-presenting cells that initiate and regulate T cell responses, thereby shaping immunity against pathogens, innocuous antigens, tumors, and self-antigens. The migration of cDCs from peripheral tissues
Audrey Meloun   +2 more
doaj   +2 more sources

Multidisciplinary management of type 2 inflammation diseases using a screening tool [PDF]

open access: yesFrontiers in Allergy
Dysregulation of type 2 (T2) immune response leads to an aberrant inflammatory reaction that constitutes the pathophysiological basis of diseases involving various organs.
Oscar Palomares   +4 more
doaj   +2 more sources

Stapokibart (CM310) targets IL-4Rα for the treatment of type 2 inflammation [PDF]

open access: yesiScience
Summary: Stapokibart (CM310) is a humanized IL-4Rα monoclonal antibody currently undergoing phase 3 trials for type 2 inflammatory diseases. In contrast to dupilumab, which bound exclusively to human IL-4Rα, stapokibart demonstrated cross-species ...
Wei Liu   +11 more
doaj   +2 more sources

Impaired tryptophan metabolism by type 2 inflammation in epithelium worsening asthma [PDF]

open access: yesiScience
Summary: Previous researches indicate that tryptophan metabolism is critical to allergic inflammation and that indoleamine 2,3-dioxygenase 1 (IDO1), as a key enzyme, is known for its immunosuppressive properties.
Yushan Miao   +8 more
doaj   +2 more sources

Correlation between bullous pemphigoid and type 2 inflammation

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU   +6 more
doaj   +1 more source

Type 2 inflammation in asthma and other airway diseases

open access: yesERJ Open Research, 2022
Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COPD and allergic rhinitis are a global health concern.
Jorge Maspero   +11 more
doaj   +1 more source

Vascular miR‐181b controls tissue factor‐dependent thrombogenicity and inflammation in type 2 diabetes [PDF]

open access: yes, 2020
BACKGROUND: Diabetes mellitus is characterized by chronic vascular inflammation leading to pathological expression of the thrombogenic full length (fl) tissue factor (TF) and its isoform alternatively-spliced (as) TF. Blood-borne TF promotes factor (
Chakraborty, Aritra   +14 more
core   +1 more source

Type 2 inflammatory diseases in atopic dermatitis: A short review

open access: yesIndian Journal of Paediatric Dermatology, 2022
Type 2 inflammatory diseases are characterized by the dysregulation of the T helper (Th) 2 pathway, the prototype being atopic dermatitis (AD). The common inflammatory pathways, genetic risk factors, epidermal barrier dysfunction, parental atopy, and ...
Ankita Choudhary   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy